New products to watch

New products to watch

Selected drugs that received regulatory approval in 2008.

Company Product Indication 2008 approval
Abbott (NYSE:ABT) Simcor extended-release niacin / immediate-release simvastatin Manage cholesterol in patients with complex lipid disease when treatment with either therapy alone is not adequate U.S.
Adolor (NASDAQ:ADLR)/ GlaxoSmithKline (LSE:GSK; NYSE:GSK) Entereg alvimopan Postoperative ileus (POI) U.S.
Alcon (NYSE:ACL) Patanase olopatadine hydrochloride nasal spray Seasonal allergic rhinitis U.S.
Allergan (NYSE:AGN) Trivaris triamcinolone Intravitreal, intramuscular or intra-articular injection to treat sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids U.S.
Allergan (NYSE:AGN) Latisse bimatoprost ophthalmic solution 0.03% Hypotrichosis

Read the full 1190 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE